Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer-Reference-Cited by-同舟云学术

Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer

Published:2013-01 Issue:1 Volume:15 Page:51-61
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Lira Maruja E.,Kim Tae Min,Huang Donghui,Deng Shibing,Koh Youngil,Jang Bogun,Go Heounjeong,Lee Se-Hoon,Chung Doo Hyun,Kim Woo Ho,Schoenmakers Eric F.P.M.,Choi Yoon-La,Park Keunchil,Ahn Jin Seok,Sun Jong-Mu,Ahn Myung-Ju,Kim Dong-Wan,Mao Mao

Funder

Korean Health Technology R&D Project

Ministry of Health and Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference27 articles.

1. Fusion of a kinase gene, ALK, to a nucleolar protein gene NPM, in non-Hodgkin’s lymphoma;Morris;Science,1994

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors;Griffin;Cancer Res,1999

4. Identification of ALK as a major familial neuroblastoma predisposition gene;Mosse;Nature,2008

5. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer;Takezawa;Clin Cancer Res,2011

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection and Validation of Chimeric RNA;PROG BIOCHEM BIOPHYS;2024

2. Diagnosis and treatment of anaplastic lymphoma kinase (ALK) rearranged non−small cell lung cancer;Lung Cancer;2024

3. Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques;Molecular Oncology;2023-06-06

4. Fluorescence In Situ Hybridization (FISH) for the Characterization and Monitoring of Primary Cultures from Human Tumors;Journal of Molecular Pathology;2023-03-14

5. Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation;Cancers;2022-12-31